Comparison of Disease Prevalence and Severity of SARS-CoV-2 Infection between Two Factory Accommodation Isolations in Southern Thailand
DOI:
https://doi.org/10.31584/psumj.2025267223Keywords:
COVID-19, factory, factory accommodation isolation (FAI), SARS-CoV-2 infectionAbstract
Objective: In 2021, the Thai Ministry of Public Health implemented policies known as “Factory Accommodation Isolation” (FAI) to provide care for confirmed patients with coronavirus disease-2019 (COVID-19). FAIs were established to alleviate strain on the healthcare system. However, the effectiveness of FAIs in alleviating COVID-19 remains unclear due to a lack of knowledge concerning the extent of the outbreak and the symptoms, severity, and management of the disease in workers’ factories. This study aimed to describe and compare the characteristics, severity, and incidence of COVID-19 cases in two FAI facilities.
Material and Methods: This cross-sectional study was conducted in two factories related to concrete manufacturing and the production of rubber gloves in Songkhla, Thailand, between October 2021 and November 2021.
Results: The prevalence of COVID-19 infection in the concrete manufacturing factory, where prevention measures for COVID-19 were implemented early, and in the rubber glove factory was 38% and 21%, respectively. Patients from the concrete manufacturing factory reported a higher prevalence of symptoms, including cough, muscle pain, loss of sense of smell, and difficulty in breathing than did those from the rubber glove factory. Patients with incomplete vaccination had a higher prevalence of respiratory symptoms.
Conclusion: FAI design, number of workers, and crowded working spaces were associated with COVID-19 outbreaks in the workplace. This study showed that caring for patients with COVID-19 in FAI facilities can be performed safely while reducing the use of medical resources and personnel, which should be reserved for severe infections.
References
World Health Organization. Coronavirus disease (COVID-19). [homepage on the Internet]. Geneva: WHO; 2023 [cited 2023 Jan 7]. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019
COVID-19 Treatment Guidelines Panel. Coronavirus Disease 2019 (COVID-19) Treatment Guidelines [monograph on the Internet]. National Institutes of Health; 2019 [cited 2023 May 02]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK570371/pdf/Bookshelf_NBK570371.pdf
World Health Organization. Coronavirus disease (COVID-19) Symptom. [homepage on the Internet] Geneva: WHO; 2021 [cited 2022 Jan 12]. Available from: https://www.who.int/westernpacific/health-topics/coronavirus
Mathieu E, Ritchie H, Rodés-Guirao L, Appel C, Giattino C, Hasell J, et al. Coronavirus Pandemic (COVID-19) [homepage on the Internet]. Our World Data; 2020 [cited 2023 Oct 1]. Available from: https://ourworldindata.org/coronavirus/country/thailand
Michaels D, Wagner GR. Occupational Safety and Health Administration (OSHA) and worker safety during the COVID-19 pandemic. JAMA 2020;324:1389. DOI: https://doi.org/10.1001/jama.2020.16343
Contreras Z, Ngo V, Pulido M, Washburn F, Meschyan G, Gluck F, et al. Industry sectors highly affected by worksite outbreaks of coronavirus disease, Los Angeles County, California, USA, March 19–September 30, 2020. Emerg Infect Dis 2021;27:1769–75. DOI: https://doi.org/10.3201/eid2707.210425
Department of disease control. Ministry of Public Health. Situation of coronavirus disease 2019 (COVID-19) public health measures and obstacles to disease prevention and control in travelers. [monograph on the nternet]. Ministry of Public Health; 2021 [cited 2022 Jan 29]. Available from: https://ddc.moph.go.th/uploads/files/2017420210820025238.pdf
Ministry of Labor. Ministry of Labor Announcement. Providing welfare of business establishments for provide accommodation for employees to protect against the risk of coronavirus disease 2019 [monograph on the Internet]. 2021 [cited 2022 Jan 12]. Available from: http://www.oic.go.th/FILEWEB/CABINFOCENTER3/DRAWER005/GENERAL/DATA0002/00002908.PDF
Department of Disease Control, Ministry of Public Health. Guide to disease prevention and control measures in specific areas (Bubble and Seal) for business establishments [monograph on the Internet]. Ministry of Publc Health; 2021 [cited 2022 Jan 12]. Available from: https://ddc.moph.go.th/uploads/publish/1183620211001030623.pdf
Health Center 5, Ratchaburi, Department of Health, Ministry of Public Health. Guidelines for establishing isolation centers for infected people with COVID-19 in factories or establishments [monograph of the Internet]. Ratchaburi: Ministry of Public Health; [cited 2022 Jan 12]. Available from: https://apps.hpc.go.th/dl/web/upFile/2021/08-1007720210826164051/d0c7fa5f844061111bad4a26f8492056.pdf
Nopparat Ratchathani Hospital, Occupational and Environmental Medicine Center. Guidelines for practice in the COVID-19 outbreak situation for establishments. Bangkok: Nopparat Ratchathani Hospital; 2021.
Buchan SA, Smith PM, Warren C, Murti M, Mustard C, Kim JH, et al. Incidence of outbreak-associated COVID-19 cases by industry in Ontario, Canada, 1 April 2020–31 March 2021. Occup Environ Med 2022;79:403-11. DOI: https://doi.org/10.1136/oemed-2021-107879
Ingram C, Downey V, Roe M, Chen Y, Archibald M, Kallas KA, et al. COVID-19 prevention and control measures in workplace settings: a rapid review and meta-analysis. Int J Environ Res Public Health 2021;18:7847.
Ingram C, Downey V, Roe M, Chen Y, Archibald M, Kallas KA, et al. COVID-19 prevention and control measures in workplace settings: a rapid review and meta-analysis. Int J Environ Res Public Health 2021;18:7847. DOI: https://doi.org/10.3390/ijerph18157847
Murti M, Achonu C, Smith BT, Brown KA, Kim JH, Johnson J, et al. COVID-19 workplace outbreaks by industry sector and their associated household transmission, Ontario, Canada, January – June, 2020. J Occup Environ Med 2021;63:574-80. DOI: https://doi.org/10.1097/JOM.0000000000002201
Davies NG, Klepac P, Liu Y, Prem K, Jit M, CMMID COVID-19 working group, et al. Age-dependent effects in the transmission and control of COVID-19 epidemics. Nat Med 2020;26:1205–11. DOI: https://doi.org/10.1038/s41591-020-0962-9
Schneiderman M, Rumain B, Kaganovskiy L, Geliebter A. Incidence and relative risk of COVID-19 in adolescents and youth compared with older adults in 19 US States, Fall 2020. JAMA Netw Open 2022;5:e2222126. DOI: https://doi.org/10.1001/jamanetworkopen.2022.22126
Kalantari H, Tabrizi AHH, Foroohi F. Determination of COVID-19 prevalence with regards to age range of patients referring to the hospitals located in western Tehran, Iran. Gene Rep 2020;21:100910. DOI: https://doi.org/10.1016/j.genrep.2020.100910
Al Kaabi N, Zhang Y, Xia S, Yang Y, Al Qahtani MM, Abdulrazzaq N, et al. Effect of 2 inactivated SARS-CoV-2 vaccines on symptomatic COVID-19 infection in adults: a randomized clinical trial. JAMA 2021;326:35. DOI: https://doi.org/10.1001/jama.2021.8565
Hu Z, Tao B, Li Z, Song Y, Yi C, Li J, et al. Effectiveness of inactivated COVID-19 vaccines against severe illness in B.1.617.2 (Delta) variant-infected patients in Jiangsu, China. Int J Infect Dis 2022;116:204-9. DOI: https://doi.org/10.1016/j.ijid.2022.01.030
Wu D, Zhang Y, Tang L, Wang F, Ye Y, Ma C, et al. Effectiveness of inactivated COVID-19 vaccines against symptomatic, pneumonia, and severe disease caused by the delta variant: real world study and evidence—China, 2021. China CDC Wkly 2022;4:57–65. DOI: https://doi.org/10.46234/ccdcw2022.009
Palacios R, Batista AP, Albuquerque CSN, Patiño EG, Santos J do P, Tilli Reis Pessoa Conde M, et al. Efficacy and safety of a COVID-19 inactivated vaccine in healthcare professionals in Brazil: the PROFISCOV study. Rochester, NY; 2021 [cited 2023 Feb 28]. Available from: https://papers.ssrn.com/abstract=3822780 DOI: https://doi.org/10.2139/ssrn.3822780
COVID-19 Treatment Guidelines Panel. Coronavirus Disease 2019 (COVID-19) Treatment Guidelines [homepage on the Internet]. National Institutes of Health; 2019 [cited 2023 May 02]. Available from: https://www.covid19treatmentguidelines.nih.gov/
Verity R, Okell LC, Dorigatti I, Winskill P, Whittaker C, Imai N, et al. Estimates of the severity of coronavirus disease 2019: a model-based analysis. Lancet Infect Dis 2020;20:669–77. DOI: https://doi.org/10.1016/S1473-3099(20)30243-7
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Author and Journal
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
